An innovative plasmacytoid dendritic cell line-based cancer vaccine primes and expands antitumor T-cells in melanoma patients in a first-in-human trial

Volume 9, Issue 1, January 2020 .

Source: OncoImmunology - April 11, 2020 Category: Cancer & Oncology Authors: Julie Charles Laurence Chaperot Dalil Hannani Juliana Bruder Costa Isabelle Templier Sabiha Trabelsi Hugo Gil Anaick Moisan Virginie Persoons Harald Hegelhofer Edith Schir Jean-Louis Quesada Christophe Mendoza Caroline Aspord Olivier Manches Pierre G. Cou Source Type: research